Press release
NASH/MASH Treatment Market: Global Scope, Industry Growth, and Regional Analysis through 2031 | Ipsen Pharma, Madrigal Pharmaceuticals, Zydus Therapeutics Inc
NASH/MASH Treatment Market
NASH/MASH Treatment Market analysis, according to DataM Intelligence, offers more than just an overview, it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Get a Free Sample PDF copy of the report - https://datamintelligence.com/download-sample/nash/mash-treatment-market
The NASH/MASH Treatment market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
NASH (Non-Alcoholic Steatohepatitis) and MASH (Metabolic Dysfunction-Associated Steatohepatitis) are liver conditions characterized by inflammation and damage caused by fat buildup in the liver, without excessive alcohol consumption. NASH is a more severe form of non-alcoholic fatty liver disease (NAFLD) and can progress to liver fibrosis, cirrhosis, or liver cancerForecast Growth Projected:
The Global NASH/MASH Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the NASH/MASH Treatment Market:
Ipsen Pharma, Madrigal Pharmaceuticals, Zydus Therapeutics Inc., Gleason Healthcare, Novo Nordisk A/S, Eli Lilly and Company, 89bio, Inc., Boehringer Ingelheim International GmbH, Akero Therapeutics, Inc. and NeuroBo Pharmaceuticals, Inc. among others.
Emerging Players
Viking Therapeutics, ICON plc, FOMAT Medical Research INC
Segment Covered in the NASH/MASH Treatment Market:
By Drug Type: Marketed Drugs, Rezdiffra , Saroglitazar, Emerging DrugsCenicriviroc (CVC) , Elafibranor, Semaglutide , Others
By Distribution Channel: Hospital Pharmacies, Online Pharmacies , Retail Pharmacies
Industry Development:
In October 2024, Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for survodutide (BI 456906), a dual glucagon/GLP-1 receptor agonist, for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced fibrosis (stages 2 or 3).
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=nash/mash-treatment-market
Regional Break out:
The global NASH/MASH Treatment Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of NASH/MASH Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of NASH/MASH Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/nash/mash-treatment-market
Frequently asked questions:
➠ What is the global sales value, production value, consumption value, import and export of NASH/MASH Treatment market?
➠ Who are the global key manufacturers of the NASH/MASH Treatment Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?
➠ What are the NASH/MASH Treatment market opportunities and threats faced by the vendors in the global NASH/MASH Treatment Industry?
➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➠ What focused approach and constraints are holding the NASH/MASH Treatment market?
➠ What are the different sales, marketing, and distribution channels in the global industry?
Transform Your Strategy with Expert Market Analysis: https://www.datamintelligence.com/competitive-intelligence
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release NASH/MASH Treatment Market: Global Scope, Industry Growth, and Regional Analysis through 2031 | Ipsen Pharma, Madrigal Pharmaceuticals, Zydus Therapeutics Inc here
News-ID: 3824287 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Recycled Plastics Market Outlook - Opportunities & Challenges - 2024-2031 | Best …
The Global Recycled Plastic Market reached US$ 48.6 billion in 2022 and is expected to reach US$ 95.5 billion by 2031, growing with a CAGR of 8.9% during the forecast period 2024-2031.
Recycled Plastic Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of…
Solar Panel Recycling Market: A Sustainable Solution for PV Waste Management To …
The Global Solar Panel Recycling Market reached US$ 155.5 million in 2023 and is expected to reach US$ 419.6 million by 2031, growing with a CAGR of 13.3% during the forecast period 2024-2031.
Solar Panel Recycling Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay…
Global Polyamide Market Insights: Growth, Share & Analysis - 2024-2031 | Major C …
The Global Polyamide Market reached USD 37.4 billion in 2022 and is expected to reach USD 60.2 billion by 2031, growing with a CAGR of 6.2% during the forecast period 2024-2031.
Polyamide Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition.…
US Glyconutritional Supplements Market: Innovation, Health Benefits & US Tariff …
The US Glyconutritional Supplements Market reached US$ 662.29 million in 2023 and is expected to reach US$ 1,324.56 million by 2031, growing at a CAGR of 9.05% from 2024 to 2031.
Us Glyconutritional Supplements Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of…
More Releases for NASH
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
IQ4I Research published “Non-alcoholic steatohepataitis (NASH) Pipeline Analys …
“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH. The report covers all the drugs that are in various phases of development (Discovery, Preclinical & Clinical). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, antibodies, stem cell therapies, recombinant proteins and RNA-based therapeutics, but excludes symptom relief drugs, generic combinations and supplemental drugs. The report…
Growing Prevalence of NASH to Increase Adoption of Therapeutics
"The Report OpportunityAnalyzer: NASH - Opportunity Analysis and Forecasts to 2026 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has itemized the addition of a new market research report to its report repository. The research publication is titled, “Opportunity Analyzer: NASH - Opportunity Analysis and Forecasts to 2026.” The statistical surveying study is a watchful inspection of the general market…
OpportunityAnalyzer: NASH - Opportunity Analysis and Forecasts to 2026
First described in 1980, nonalcoholic steatohepatitis (NASH) (ICD-10-CM = K75.81) is a condition that develops as a subgroup of nonalcoholic fatty liver disease (NAFLD) when excessive fat buildup is accompanied by liver cell injury and inflammation. NAFLD is defined by excessive fat accumulation in the form of triglycerides (steatosis) in the liver. Progression of this condition to NASH dramatically increases the risk of cirrhosis, liver failure, and hepatocellular carcinoma, and…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
